SCHEMBL1029702

SCHEMBL1029702

CC(=O)Oc1ccc2c(c1)Oc1cc(OC(C)=O)ccc1C21OC(=O)c2c(C(=O)O)cccc21

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.67
MAPT P10636 3/20 0.67
MEN1 O00255 2/20 0.67
HTT P42858 2/20 0.67
KMT2A Q03164 2/20 0.67
LMNA P02545 2/20 0.67
USP2 O75604 1/20 0.67
GSTP1 P09211 1/20 0.57
CYP3A4 P08684 2/20 0.45
KDM4E B2RXH2 3/20 0.41
HPGD P15428 3/20 0.41
HSD17B10 Q99714 2/20 0.41
CYP2C9 P11712 1/20 0.41
ALOX15 P16050 1/20 0.41
ALOX12 P18054 1/20 0.41
BRCA1 P38398 1/20 0.41
FTO Q9C0B1 3/20 0.39
CYP2C19 P33261 1/20 0.39
RECQL P46063 1/20 0.39
BLM P54132 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL991486 0.95 MAPT (0.61) ALDH1A1MAPTMEN1HTTKMT2A
SCHEMBL4961814 0.90 ALDH1A1 (0.54) ALDH1A1MAPTMEN1HTTKMT2A
SCHEMBL4230526 0.89 ALDH1A1 (0.53) ALDH1A1MAPTMEN1HTTKMT2A
SCHEMBL31110332 0.88 MAPT (0.53) ALDH1A1MAPTMEN1HTTKMT2A
SCHEMBL6523127 0.88 MAPT (0.62) ALDH1A1MAPTMEN1HTTKMT2A
SCHEMBL7723312 0.86 ALDH1A1 (0.61) ALDH1A1MAPTMEN1HTTKMT2A
SCHEMBL5697654 0.86 HPGD (0.51) ALDH1A1MAPTMEN1HTTKMT2A
SCHEMBL5445148 0.85 MEN1 (0.68) ALDH1A1MAPTMEN1HTTKMT2A
SCHEMBL23029210 0.84 MEN1 (0.70) ALDH1A1MAPTMEN1HTTKMT2A
SCHEMBL1228074 0.84 ALDH1A1 (0.58) ALDH1A1MAPTMEN1HTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2640843-B1 VIABILITY CELL COUNTING BY DIFFERENTIAL LIGHT ABSORPTION BIO RAD LABORATORIES (US) 2016-02-24 EP claimed
WO-2015024576-A1 POLYMER-BOUND IODINE AS A QUENCHER FOR FLUORESCENCE MEASUREMENTS TESTO AG (DE) 2015-02-26 WO claimed
EP-1539994-B1 METHOD OF MONITORING BIOFOULING IN MEMBRANE SEPARATION SYSTEMS NALCO CO (US) 2009-09-16 EP claimed
EP-4259715-A1 CONFIGURABLE HYDROGEL MATERIAL AND METHOD FOR CONFIGURING HYDROGEL MATERIALS FOR SEQUESTRATION AND/OR RELEASE OF BIOACTIVE SUBSTANCES Leibniz-Institut für Polymerforschung Dresden e.V. (DE) 2023-10-18 EP disclosed
WO-2022111756-A9 CONFIGURABLE HYDROGEL MATERIAL AND METHOD FOR CONFIGURING HYDROGEL MATERIALS FOR SEQUESTRATION AND/OR RELEASE OF BIOACTIVE SUBSTANCES Leibniz-Institut für Polymerforschung Dresden e. V. (DE) 2023-05-25 WO disclosed
WO-2022111756-A1 CONFIGURABLE HYDROGEL MATERIAL AND METHOD FOR CONFIGURING HYDROGEL MATERIALS FOR SEQUESTRATION AND/OR RELEASE OF BIOACTIVE SUBSTANCES Leibniz-Institut für Polymerforschung Dresden e. V. (DE) 2022-06-02 WO disclosed
US-20210115458-A1 COMPOSITION FOR INCREASING NUTRIENT STORAGE CAPACITY OF PLANT NUTRIENT STORAGE TISSUES, CONTAINING JULGI PROTEIN EXPRESSION OR ACTIVITY INHIBITOR POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) 2021-04-22 US disclosed
EP-3587554-B1 METHOD FOR ACCELERATED DETERMINATION OF THE CONCENTRATION OF LIVING THERMOPHILIC BACTERIA IN WATER-BEARING INSTALLATIONS INWATEC GMBH & CO KG (DE) 2020-12-23 EP disclosed
US-10605738-B2 Device for microbiological analysis EMD MILLIPORE CORPORATION (US) 2020-03-31 US disclosed
US-10605739-B2 Device for microbiological analysis EMD MILLIPORE CORPORATION (US) 2020-03-31 US disclosed
WO-2019190081-A1 COMPOSITION FOR INCREASING NUTRIENT STORAGE CAPACITY OF PLANT NUTRIENT STORAGE TISSUES, CONTAINING JULGI PROTEIN EXPRESSION OR ACTIVITY INHIBITOR 포항공과대학교 산학협력단 2019-10-03 WO disclosed
US-20030044978-A1 EXPANDED AND GENETICALLY MODIFIED POPULATIONS OF HUMAN HEMATOPOIETIC STEM CELLS NOVARTIS CORPORATION 2003-03-06 US disclosed
EP-1204430-A2 CONJUGATES AND METHODS FOR THE PRODUCTION THEREOF, AND THEIR USE FOR TRANSPORTING MOLECULES VIA BIOLOGICAL MEMBRANES Aventis Pharma Deutschland GmbH (DE) 2002-05-15 EP disclosed
EP-1129175-A2 PROMOTION OF SELF-RENEWAL AND IMPROVED GENE TRANSDUCTION OF HEMATOPOIETIC STEM CELLS BY HISTONE DEACETYLASE INHIBITORS Novartis AG (CH) 2001-09-05 EP disclosed
WO-2001008707-A2 CONJUGATES AND METHODS FOR THE PRODUCTION THEREOF, AND THEIR USE FOR TRANSPORTING MOLECULES VIA BIOLOGICAL MEMBRANES AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2001-02-08 WO disclosed
EP-1053302-A2 EXPANDED AND GENETICALLY MODIFIED POPULATIONS OF HUMAN HEMATOPOIETIC STEM CELLS Novartis AG (CH) 2000-11-22 EP disclosed
WO-2000023567-A2 PROMOTION OF SELF-RENEWAL AND IMPROVED GENE TRANSDUCTION OF HEMATOPOIETIC STEM CELLS BY HISTONE DEACETYLASE INHIBITORS NOVARTIS AG (CH) 2000-04-27 WO disclosed
WO-1999040180-A9 EXPANDED AND GENETICALLY MODIFIED POPULATIONS OF HUMAN HEMATOPOIETIC STEM CELLS NOVARTIS AG (CH) 1999-11-25 WO disclosed
WO-1999040180-A2 EXPANDED AND GENETICALLY MODIFIED POPULATIONS OF HUMAN HEMATOPOIETIC STEM CELLS NOVARTIS AG (CH) 1999-08-12 WO disclosed
EP-0336281-B1 PROCESS FOR CONTROLLING BIOLOGICAL CLARIFICATION STAGES ORPEGEN MEDIZINISCH-MOLEKULARBIOLOGISCHE FORSCHUNGSGESELLSCHAFT m.b.H. (DE) 1992-03-11 EP disclosed